Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Bateman-House

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Pediatrics|November 8, 2018
Ethical Issues in Gender-Affirming Care for YouthLaura L Kimberly, Kelly McBride Folkers, Phoebe Friesen, et al.
Journal of Neuromuscular Diseases|August 2, 2024
Clinician Perspectives of Gene Therapy as a Treatment Option for Duchenne Muscular DystrophyHeidi Cope, Ryan Fischer, Emma Heslop, et al.
Transplantation and Cellular Therapy|May 18, 2024
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell TherapiesRebecca A Gardner, Claire White, Magdi Elsallab, et al.
European Journal of Medical Genetics|October 11, 2025
Re-evaluating acceptable risk of death from gene therapy: A threshold study among individuals with Duchenne muscular dystrophy and their caregivers in the US and UKHolly Peay, Ryan Fischer, Megan McNiff, et al.
Therapeutic Advances in Rare Disease|May 29, 2025
From roadmap to a sustainable end-to-end individualized therapy pathwayAnneliene H Jonker, Elena-Alexandra Tataru, David P Dimmock, et al.
Science (New York, N.Y.)|July 16, 2005
Ethics: Moral issues of human-non-human primate neural graftingMark Greene, Kathryn Schill, Shoji Takahashi, et al.
Nature Reviews. Drug Discovery|November 4, 2024
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmapAnneliene H Jonker, Elena-Alexandra Tataru, Holm Graessner, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2019
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncologyRoberto Salgado, David B Solit, David L Rimm, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Pediatrics|November 8, 2018
Ethical Issues in Gender-Affirming Care for YouthLaura L Kimberly, Kelly McBride Folkers, Phoebe Friesen, et al.
Journal of Neuromuscular Diseases|August 2, 2024
Clinician Perspectives of Gene Therapy as a Treatment Option for Duchenne Muscular DystrophyHeidi Cope, Ryan Fischer, Emma Heslop, et al.
Transplantation and Cellular Therapy|May 18, 2024
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell TherapiesRebecca A Gardner, Claire White, Magdi Elsallab, et al.
European Journal of Medical Genetics|October 11, 2025
Re-evaluating acceptable risk of death from gene therapy: A threshold study among individuals with Duchenne muscular dystrophy and their caregivers in the US and UKHolly Peay, Ryan Fischer, Megan McNiff, et al.
Therapeutic Advances in Rare Disease|May 29, 2025
From roadmap to a sustainable end-to-end individualized therapy pathwayAnneliene H Jonker, Elena-Alexandra Tataru, David P Dimmock, et al.
Science (New York, N.Y.)|July 16, 2005
Ethics: Moral issues of human-non-human primate neural graftingMark Greene, Kathryn Schill, Shoji Takahashi, et al.
Nature Reviews. Drug Discovery|November 4, 2024
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmapAnneliene H Jonker, Elena-Alexandra Tataru, Holm Graessner, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2019
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncologyRoberto Salgado, David B Solit, David L Rimm, et al.
Pageof 5